The geoepidemiology of systemic lupus erythematosus
Introduction
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with a plethora of immunological and laboratory abnormalities, and clinical manifestations. There clearly is a genetic component to lupus susceptibility. It is generally accepted, however, that environmental or other factors are required as triggers of disease development. Lupus can affect almost every organ, most prominently and devastatingly the kidney and the central nervous system. Its severity in individual patients can range from mild cutaneous involvement to severe organ damage, its outcome from lasting remission to death. In addition, disease activity can fluctuate greatly, with most patients experiencing disease flares alternating with prolonged periods of remission. The clinical manifestations of SLE differ not only from patient to patient, but also show considerable geographic or ethnic variation between populations (see Table 1). Similar variation is obvious in disease activity and accrual of organ damage. Note that the comparison of disease activity between different cohorts has been greatly facilitated by the development of standardized and validated tools for assessing disease activity. These include the SLE Disease Activity Index (SLEDAI, SLEDAI-2K if the revised version is used), the European Consensus Lupus Activity Measure (ECLAM), and the Systemic Lupus Activity Measure (SLAM, SLAM-R, Bilag, if the revised version is used). Whereas no international consensus has yet been reached concerning the best tool for assessing disease activity, the Systemic Lupus International Collaborating Clinics (SLICC)/ACR Damage Index (SDI) is in worldwide use for determining organ damage. It measures irreversible change attributable not only to lupus itself, but also to concomitant diseases or treatment, in 12 organs or systems.
This chapter will attempt to provide an overview of the genetic basis of SLE and the major geographical and ethnic differences in the frequency and severity of clinical manifestations. This will be followed by a discussion of the factors that are thought to play a role in these ethnic differences, focusing specifically on two of the major clinical manifestations of SLE, namely renal and neuropsychiatric involvement, and two commonly used outcome measures, disease activity and overall organ damage. Despite considerably improved survival probabilities in recent decades, the ultimate outcome measure in SLE remains mortality. Therefore, this chapter also includes a brief discussion of geographic and ethnic differences in survival probabilities and causes of death.
Several aspects of lupus are beyond the scope of this chapter. 1) The antiphospholipid syndrome is an important issue in SLE since it affects between 6% and 30% of patients in different cohorts and is associated with significant morbidity and mortality, but is addressed in a separate chapter and will not be a major focus here. 2) SLE most frequently affects adult women, but in about 15–20% of cases, disease onset occurs during childhood. The disease course in childhood onset lupus seems to differ from that seen in adult-onset disease, being more severe with faster and more severe damage accrual. Because of these differences, studies of childhood onset SLE will not be included here.
Section snippets
Incidence and prevalence and gender distribution of SLE
The ascertainment of SLE incidence and prevalence faces several difficulties. Many of the existing studies were based on small source populations and cases were ascertained in the absence of standardized diagnostic criteria. Some of the more recent studies are based on self-report or on health system databases. Both approaches have shown poor reliability and yield only rough estimates. In addition, the relapsing–remitting course of the disease in individual patients and the long duration of
Genetics
Concordance rates of 24–58% in monozygotic twins compared to 2–5% in dizygotic twins indicate that there is a substantial genetic component to SLE susceptibility. This is further supported by the increased frequency of SLE – and other autoimmune diseases – in family members of SLE patients compared to the general population. The frequency of familial SLE overall appears to be in the range of 8–10%, the rates being similar in Europeans, Latin Americans, African Americans, Afro-Caribbeans, and
Clinical profiles of different populations
The frequencies of the individual clinical manifestations of SLE show substantial geographic or ethnic variation (see Table 2). Despite the considerable heterogeneity even within the major continental ethnic groups, certain patterns have emerged. Europeans and their descendants in other parts of the world generally show more frequent mucocutaneous manifestations, in particular photosensitivity, compared to most other ethnic groups [45], [46], [47]. However, SLE patients of African descent more
Survival probabilities and standardized mortality rates
There is overwhelming evidence that the probability of surviving 5 years after diagnosis of SLE increased from < 50% in the 1950s to ∼ 95% in the most recent studies [82], [83], [84], [85]. Nonetheless, the standardized mortality ratios (SMRs) for SLE patients remain 2–4-fold higher compared to the general population. In the Hopkins Lupus Cohort, survival probabilities were 95%, 91% 85% and 78% at 5, 10, 15 and 20 years after diagnosis, respectively [83]. Very similar survival rates have been
Concluding remarks
There are clear geographical and ethnic differences in the incidence, clinical course, and outcome of SLE. Numerous studies have investigated the confounding of the ethnicity effect by indicators of socioeconomic status. The results suggest that ethnicity is a more important determinant of renal and neuropsychiatric involvement and damage than socioeconomic factors. Both ethnicity and socioeconomic status are independently associated with disease activity and overall organ damage. However, the
Take-home messages
- •
SLE affects essentially all other ethnic groups more frequently than Europeans and their descendants
- •
SLE generally is less severe in Europeans compared to most other ethnic groups
- •
Genetic, environmental, sociodemographic and cultural factors all contribute to the different geographical/ethnic distribution and severity of clinical manifestations.
References (101)
- et al.
Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK
Lancet
(2001) - et al.
Lupus systémique en Martinique: enquête épidémiologique
Rev Med Interne
(2002) - et al.
Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus
Autoimmun Rev
(2008) - et al.
Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility
Hum Immunol
(2001) Socioeconomic status and the incidence of ESRD
Am J Kidney Dis
(2008)- et al.
Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus
Autoimmun Rev
(2004) - et al.
Lupus in the developing world—is it any different?
Best Pract Res Clin Rheumatol
(2008) - et al.
Population-based lupus registries: advancing our epidemiologic understanding
Arthritis Rheum
(2009) - et al.
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden
Lupus
(2006) - et al.
Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data
Arthritis Rheum
(2007)
Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil)
Lupus
Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992
Arthritis Rheum
Incidence of systemic lupus erythematosus. Race and gender differences
Arthritis Rheum
Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii
Arthritis Rheum
Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico
J Clin Rheumatol
The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the “prevalence gradient hypothesis”
Arthritis Rheum
Causes and predictors of death in South Africans with systemic lupus erythematosus
Rheumatology (Oxford)
Pattern of systemic lupus erythematosus among Nigerians
Clin Rheumatol
The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth
Arthritis Rheum
Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation
Ann Rheum Dis
Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman
Rheumatol Int
Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus
Mod Rheumatol
Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000–2006
J Rheumatol
Systemic lupus erythematosus in India
Lupus
Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia
Lupus
Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans
Lupus
Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort
Arthritis Rheum
Autoantibody prevalence and lupus characteristics in a unique African American population
Arthritis Rheum
The genetics of SLE: an update in the light of genome-wide association studies
Rheumatology (Oxford)
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
Nat Genet
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture
Arthritis Rheum
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets
Medicine (Baltimore)
Systemic lupus erythematosus in southern Spain: a comparative clinical and genetic study between Caucasian and Gypsy patients
Lupus
Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients
Lupus
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus
Nat Genet
Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans
Hum Genet
Genetic studies of systemic lupus erythematosus in Asia: where are we now?
Genes Immun
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans
Genes Immun
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
Hum Mol Genet
Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese
Genes Immun
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups
Arthritis Rheum
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk
Ann Rheum Dis
A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus
Nat Genet
Admixture in Hispanic Americans: its impact on ITGAM association and implications for admixture mapping in SLE
Genes Immun
Amerindian ancestry in Argentina is associated with increased risk for systemic lupus erythematosus
Genes Immun
Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population
Hum Genet
European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus
Arthritis Rheum
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort
J Rheumatol
Baseline characteristics of a multiethnic lupus cohort: PROFILE
Lupus
Systemic lupus erythematosus in the far north of Queensland
Lupus
Cited by (262)
Integrated analysis of microbiome and host transcriptome reveals the damage/protective mechanism of corn oil and olive oil on the gut health of grouper (♀ Epinephelus fuscoguttatus × ♂ E. lanceolatu)
2023, International Journal of Biological MacromoleculesThe Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies
2023, Seminars in Ultrasound, CT and MRILupus nephritis, an update
2023, Revista Colombiana de Reumatologia